No.

Publication Date

Citing Article

1

2025

Uddalak Das, Tathagata Chanda, Jitendra Kumar, Anitha Peter. Discovery of natural MCL1 inhibitors using pharmacophore modelling, QSAR, docking, ADMET, molecular dynamics, and DFT analysis, Computational Biology and Chemistry. 2025; 117: 108427108427.  https://doi.org/10.1016/j.compbiolchem.2025.108427

2

2024

Hongguang Deng, Yu Han, Liang Liu, Hong Zhang, Dan Liu, Jiachen Wen, Min Huang, Linxiang Zhao. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions, Journal of Medicinal Chemistry. 2024; 67: 5963.  https://doi.org/10.1021/acs.jmedchem.3c01998

3

2024

Uddalak Das, Tathagata Chanda, Jitendra Kumar, Anitha Peter. 2024;   https://doi.org/10.1101/2024.10.14.618373

4

2023

Wanqing Wang, Kaipeng Jiang, Xue Liu, Ju Li, Wenshuo Zhou, Chang Wang, Jiuwei Cui, Tingting Liang. FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies, Frontiers in Pharmacology. 2023; 14: 1278056.  https://doi.org/10.3389/fphar.2023.1278056

5

2023

Wentao Bo, Yan Chen. Lenvatinib resistance mechanism and potential ways to conquer, Frontiers in Pharmacology. 2023; 14: 1153991.  https://doi.org/10.3389/fphar.2023.1153991

6

2024

Gu-Choul Shin, Hyeong Min Lee, Nayeon Kim, Sang-Uk Seo, Kwang Pyo Kim, Kyun-Hwan Kim. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer, Experimental & Molecular Medicine. 2024; 56: 192.  https://doi.org/10.1038/s12276-023-01147-1

7

2024

Ling He, Hongwei Wu, Zhiqiang Sun, Jie Zhang. Inhibition of Multiple Myeloma Growth by Wogonin Involves Mitochondrial Apoptosis and G2/M Cycle Arrest, International Journal of Pharmacology. 2024; 20: 166.  https://doi.org/10.3923/ijp.2024.166.173

8

2022

Mariana Tannoury, Delphine Garnier, Santos A. Susin, Brigitte Bauvois. Current Status of Novel Agents for the Treatment of B Cell Malignancies: What’s Coming Next?, Cancers. 2022; 14: 6026.  https://doi.org/10.3390/cancers14246026

9

2023

Shady I. Tantawy, Natalia Timofeeva, Aloke Sarkar, Varsha Gandhi. Targeting MCL-1 protein to treat cancer: opportunities and challenges, Frontiers in Oncology. 2023; 13: 1226289.  https://doi.org/10.3389/fonc.2023.1226289

10

2024

Fatimah Alharbi, Eyad Almanifi, Md. Ashrafuzzaman. Targeting BCL-2 family proteins using BH3 mimetic drugs for cancer therapy: A systematic review of randomized clinical trials, Medicine in Drug Discovery. 2024; 24: 100199100199.  https://doi.org/10.1016/j.medidd.2024.100199

11

2023

Hongping Shen, Yiting Wei, Qunying Yang, Yili Cai, Keqi Zhu, Xueqin Chen. Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells, Toxicology in Vitro. 2023; 91: 105627105627.  https://doi.org/10.1016/j.tiv.2023.105627

12

2024

Masoumeh Vakili-Azghandi, Khalil Abnous, Ali Aliabadi, Seyed Mohammad Taghdisi, Asma Ghaemi, Mohammad Ramezani, Mona Alibolandi. Poly(2-(dimethylamino) ethyl methacrylate)-b-poly (hydroxy propyl methacrylate) nanoparticles for guided delivery of MCL-1 CRISPR-Cas9 plasmid and doxorubicin to non-small cell lung cancer, European Polymer Journal. 2024; 219: 113408113408.  https://doi.org/10.1016/j.eurpolymj.2024.113408

13

2023

Shuai Zhao, Tiantian Gu, Kaiqi Weng, Yu Zhang, Zhengfeng Cao, Yang Zhang, Wenming Zhao, Guohong Chen, Qi Xu. Phosphoproteome Reveals Extracellular Regulated Protein Kinase Phosphorylation Mediated by Mitogen-Activated Protein Kinase Kinase-Regulating Granulosa Cell Apoptosis in Broody Geese, International Journal of Molecular Sciences. 2023; 24: 12278.  https://doi.org/10.3390/ijms241512278